businessNovo Nordisk CEO Lars Fruergaard Jørgensen Defends US Ozempic and Wegovy Prices Before Senate Committee
Novo Nordisk chief executive Lars Fruergaard Jørgensen testified before the US Senate HELP Committee, defending high US prices for blockbusters Ozempic and Wegovy while deflecting blame to pharmacy benefit managers.